Movement Alert｜XtalPi Holdings Rises 5.38% in Regular Trading, Life Sciences Sector Broadly Strengthens as Broker Initiates Overweight Rating

Market Focus07-15

On July 15, XtalPi Holdings rose 5.38% in regular trading, trading at HK$7.77/share, with turnover of HK$105 million. The Life Sciences Tools & Services sector saw broad-based gains, with JOINN up 13.06%, Insilico Medicine up 8.05%, Wuxi Biologics up 4.97%, Wuxi AppTec up 4.87%, and Pharmaron up 4.83%.

On the catalyst front, Guohai Securities recently initiated coverage on XtalPi with an Overweight rating, highlighting the company's AI + Robotics + Multi-Agent R&D paradigm as a core growth driver. The broker projects revenues of RMB 1.033/1.398/1.815 billion for 2026/2027/2028, with net profit forecast at RMB 0.04/0.89/2.35 billion respectively. The company delivered a strong turnaround in full-year results, with revenue reaching RMB 803 million, up over 200% year-over-year, while swinging to a profit of RMB 135 million versus a prior-year loss of RMB 1.515 billion.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113117521?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 10:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113117521","market":"hk","top_or_hot":-1,"title":"Movement Alert｜XtalPi Holdings Rises 5.38% in Regular Trading, Life Sciences Sector Broadly Strengthens as Broker Initiates Overweight Rating","media":"Market Focus","content":"<p><p>On July 15, XtalPi Holdings rose 5.38% in regular trading, trading at HK$7.77/share, with turnover of HK$105 million. The Life Sciences Tools & Services sector saw broad-based gains, with JOINN up 13.06%, Insilico Medicine up 8.05%, Wuxi Biologics up 4.97%, Wuxi AppTec up 4.87%, and Pharmaron up 4.83%.</p><p>On the catalyst front, Guohai Securities recently initiated coverage on XtalPi with an Overweight rating, highlighting the company's AI + Robotics + Multi-Agent R&D paradigm as a core growth driver. The broker projects revenues of RMB 1.033/1.398/1.815 billion for 2026/2027/2028, with net profit forecast at RMB 0.04/0.89/2.35 billion respectively. The company delivered a strong turnaround in full-year results, with revenue reaching RMB 803 million, up over 200% year-over-year, while swinging to a profit of RMB 135 million versus a prior-year loss of RMB 1.515 billion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜XtalPi Holdings Rises 5.38% in Regular Trading, Life Sciences Sector Broadly Strengthens as Broker Initiates Overweight Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜XtalPi Holdings Rises 5.38% in Regular Trading, Life Sciences Sector Broadly Strengthens as Broker Initiates Overweight Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-15 10:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 15, XtalPi Holdings rose 5.38% in regular trading, trading at HK$7.77/share, with turnover of HK$105 million. The Life Sciences Tools & Services sector saw broad-based gains, with JOINN up 13.06%, Insilico Medicine up 8.05%, Wuxi Biologics up 4.97%, Wuxi AppTec up 4.87%, and Pharmaron up 4.83%.</p><p>On the catalyst front, Guohai Securities recently initiated coverage on XtalPi with an Overweight rating, highlighting the company's AI + Robotics + Multi-Agent R&D paradigm as a core growth driver. The broker projects revenues of RMB 1.033/1.398/1.815 billion for 2026/2027/2028, with net profit forecast at RMB 0.04/0.89/2.35 billion respectively. The company delivered a strong turnaround in full-year results, with revenue reaching RMB 803 million, up over 200% year-over-year, while swinging to a profit of RMB 135 million versus a prior-year loss of RMB 1.515 billion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02228","symbol_name":"晶泰控股","start_time":0,"source_url":"","article_id":"1113117521","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113117521","pubTimestamp":1784080850,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 15, XtalPi Holdings rose 5.38% in regular trading, trading at HK$7.77/share, with turnover of HK$105 million. The Life Sciences Tools & Services sector saw broad-based gains, with JOINN up...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02228":"晶泰控股"},"translate_title":"走势警报|XtalPi Holdings 在常规交易中上涨 5.38%，随着经纪商启动跑赢大盘评级，生命科学板块普遍走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02228":1},"content_text":"On July 15, XtalPi Holdings rose 5.38% in regular trading, trading at HK$7.77/share, with turnover of HK$105 million. The Life Sciences Tools & Services sector saw broad-based gains, with JOINN up 13.06%, Insilico Medicine up 8.05%, Wuxi Biologics up 4.97%, Wuxi AppTec up 4.87%, and Pharmaron up 4.83%.On the catalyst front, Guohai Securities recently initiated coverage on XtalPi with an Overweight rating, highlighting the company's AI + Robotics + Multi-Agent R&D paradigm as a core growth driver. The broker projects revenues of RMB 1.033/1.398/1.815 billion for 2026/2027/2028, with net profit forecast at RMB 0.04/0.89/2.35 billion respectively. The company delivered a strong turnaround in full-year results, with revenue reaching RMB 803 million, up over 200% year-over-year, while swinging to a profit of RMB 135 million versus a prior-year loss of RMB 1.515 billion.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113117521","isCrawlerRequest":true}